Bank of America’s Lixte Biotechnology Warrants LIXTW Stock Holding History

Bank of America’s Portfolio LIXTW Stock Details LIXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$3	–	8536
2025 Q2	$3	Hold	100	–	–	﹤0.01%	8337
2025 Q1	$2	Buy	+100	New	+$3	﹤0.01%	8265
2024 Q2	–	Sell	-100	Closed	-$5	–	8330
2024 Q1	$5	Buy	+100	New	+$7	﹤0.01%	7587

Other funds holding LIXTW

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's LIXTW Position: Q3 2025 in Review

Bank of America sold out of Lixte Biotechnology Warrants (LIXTW) in Q3 2025, closing a stake of 100 shares — an estimated $3 sold.

Bank of America first reported a position in LIXTW in Q1 2024 and held it in 3 quarters. The position peaked at $5 in Q1 2024. 3 funds tracked by Wall St. Rank hold LIXTW as of Q3 2025.

Bank of America reported no remaining Lixte Biotechnology Warrants position as of Q3 2025 after selling out during the quarter.
Bank of America sold 100 Lixte Biotechnology Warrants shares in Q3 2025, an estimated $3.
Bank of America first reported a position in Lixte Biotechnology Warrants in Q1 2024 and held it in 3 quarters.
Bank of America's Lixte Biotechnology Warrants position peaked at $5 in Q1 2024.
3 funds tracked by Wall St. Rank held Lixte Biotechnology Warrants as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.